Cargando…
Extended-release morphine sulfate in treatment of severe acute and chronic pain
Morphine is the archetypal opioid analgesic. Because it is a short-acting opioid, its use has been limited to the management of acute pain. The development of extended-release formulations have resulted in the increased utilization of morphine in chronic pain conditions. This review documents the hi...
Autores principales: | Balch, Robert J, Trescot, Andrea |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3004644/ https://www.ncbi.nlm.nih.gov/pubmed/21197323 http://dx.doi.org/10.2147/JPR.S6529 |
Ejemplares similares
-
Effectiveness and safety of morphine sulfate extended-release capsules in patients with chronic, moderate-to-severe pain in a primary care setting
por: Brown, James, et al.
Publicado: (2011) -
Tapentadol Extended Release in the Treatment of Severe Chronic Low Back Pain and Osteoarthritis Pain
por: Pergolizzi, Joseph V., et al.
Publicado: (2018) -
Extended-release hydrocodone – gift or curse?
por: Krashin, Daniel, et al.
Publicado: (2013) -
Developments in managing severe chronic pain: role of oxycodone–naloxone extended release
por: Fanelli, Guido, et al.
Publicado: (2015) -
Tapentadol extended-release for treatment of chronic pain: a review
por: Vadivelu, Nalini, et al.
Publicado: (2011)